Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: A clinical and pathologic study
- 1 October 1995
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 33 (4), 637-645
- https://doi.org/10.1016/0190-9622(95)91286-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skinJournal of the American Academy of Dermatology, 1994
- The mechanisms of action of cyclosporin A in the treatment of psoriasisImmunology Today, 1993
- Anthralin Decreases Keratinocyte TGF-α Expression and EGF-Receptor Binding In VitroJournal of Investigative Dermatology, 1992
- Studies of the Effect of Cyclosporine in Psoriasis In Vivo: Combined Effects on Activated T Lymphocytes and Epidermal Regenerative MaturationJournal of Investigative Dermatology, 1992
- Lymphocyte Trafficking in Psoriasis: A New Perspective Emphasizing the Dermal Dendrocyte with Active Dermal Recruitment Mediated Via Endothelial Cells Followed by Intra-Epidermal T-Cell ActivationJournal of Investigative Dermatology, 1990
- Predominance of ?memory? T cells (CD4+, CDw29+) over ?naive? T cells (CD4+, CD45R+) in both normal and diseased human skinArchives of Dermatological Research, 1989
- Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimensBritish Journal of Dermatology, 1989
- Role of Transforming Growth Factor Beta in the Maturation of Human Epidermal KeratinocytesJournal of Investigative Dermatology, 1988
- Changes in Keratinocyte Maturation During Wound HealingJournal of Investigative Dermatology, 1987
- Clearance of chronic plaque psoriasis by anthralin—subjective and objective assessment and comparison with photochemotherapyBritish Journal of Dermatology, 1981